Ownership

Michel Dahan - Insider Trading & Ownership

Entity: Individual
Location: C/O Akebia Therapeutics, Inc., 245 First Street, Suite 1100, Cambridge, MA
Summary: The estimated net worth of Michel Dahan is at least $847K dollars as of May 14, 2024. Michel Dahan is the SVP, Chief Operating Officer of Akebia Therapeutics, Inc. and owns shares of Akebia Therapeutics, Inc. (AKBA) stock worth about $847K.
All Insider Reports: All Insider Reports

Ownership of Michel Dahan

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
AKBA	Akebia Therapeutics, Inc.	SVP, Chief Operating Officer	$847K	-$43.9K	-4.93%	May 13, 2024

Showing 1 to 1 of 1 entries

Insider Transactions Reported by Michel Dahan:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership
AKBA	Akebia Therapeutics, Inc.	Common Stock	Sale	-4.93%	-$43.9K	1.26	-34.8K	672K	5/13/2024	Direct
AKBA	Akebia Therapeutics, Inc.	Common Stock	Sale	-1.21%	-$13.7K	1.58	-8.66K	707K	2/29/2024	Direct
AKBA	Akebia Therapeutics, Inc.	Common Stock	Sale	-1.48%	-$16.3K	1.52	-10.7K	716K	2/27/2024	Direct
AKBA	Akebia Therapeutics, Inc.	Common Stock	Award	+25.9%	$0	0.00	+149K	726K	1/31/2024	Direct
AKBA	Akebia Therapeutics, Inc.	Stock Option (Right to buy)	Award		$0	0.00	+224K	224K	1/31/2024	Direct
AKBA	Akebia Therapeutics, Inc.	Common Stock	Sale	-14.3%	-$117K	1.22	-95.5K	574K	5/25/2023	Direct
AKBA	Akebia Therapeutics, Inc.	Common Stock	Award	+42.6%	$0	0.00	+200K	670K	5/24/2023	Direct
AKBA	Akebia Therapeutics, Inc.	Employee Stock Option (Right to buy)	Award		$0	0.00	+200K	200K	5/24/2023	Direct
AKBA	Akebia Therapeutics, Inc.	Common Stock	Award	+74.2%	$0	0.00	+200K	470K	5/12/2023	Direct
AKBA	Akebia Therapeutics, Inc.	Common Stock	Sale	-7.04%	-$17.9K	0.88	-20.4K	270K	3/1/2023	Direct
AKBA	Akebia Therapeutics, Inc.	Common Stock	Sale	-3.36%	-$8.21K	0.81	-10.1K	290K	2/27/2023	Direct
AKBA	Akebia Therapeutics, Inc.	Common Stock	Sale	-4.83%	-$32.5K	2.17	-15K	295K	3/1/2022	Direct
AKBA	Akebia Therapeutics, Inc.	Common Stock	Award	+19.3%	$0	0.00	+50K	309K	2/28/2022	Direct
AKBA	Akebia Therapeutics, Inc.	Common Stock	Sale	-2.47%	-$14.1K	2.15	-6.56K	259K	2/28/2022	Direct
AKBA	Akebia Therapeutics, Inc.	Employee Stock Option (Right to buy)	Award		$0	0.00	+200K	200K	2/28/2022	Direct

Showing 1 to 15 of 15 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.